Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

SAN DIEGO--(BUSINESS WIRE)--Apr 10, 2025--

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%, 3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia and increase time in range. 4-8

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410304660/en/

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing. We look forward to bringing it to market in the second half of this year, but in the meantime, we encourage our users to upgrade to our current G7 system to gain the benefits of the most connected CGM brand in the world.”

New with Dexcom G7 15 Day

Dexcom G7 features included with Dexcom G7 15 Day

“Dexcom G7 15 Day makes managing diabetes even easier with its extended wear and greater accuracy,” said Satish Garg, MD, from Barbara David Center for Diabetes at the University of Colorado School of Medicine. “Data recently released during the 18th international Advanced Technologies and Treatments for Diabetes conference in Amsterdam supports that G7 15 Day is the most accurate CGM for adults.”

Dexcom is working closely with its insulin pump partners to ensure that Dexcom G7 15 Day will be compatible with automated insulin delivery systems upon launch. Dexcom G7 15 Day is expected to launch in the US in the second half of 2025.

VisitDexcom.com/startto get started with Dexcom G7 today. To learn more about Dexcom G7 15 Day and for additional information about when it will be available in the US, visitDexcom.com/15day.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

* A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days. † Excludes implantable CGM systems. ‡ Compared to a prior generation Dexcom CGM System. § The Dexcom G7 Sensor is water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. || Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. ¶ Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. # Automated activity and medication logging available in Dexcom G7 app only. ** Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/registration. †† An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity. ‡‡ Separate Dexcom Follow app and internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.

1 Dexcom, Data on File, 2025. 2 Dexcom, Data on File, 2023. 3 Garg SK, et al. Diabetes Technol Ther. 2025. doi: 10.1089/dia.2025.0139. Epub ahead of print. 4 Beck RW, et al. JAMA. 2017;317(4):371-378. 5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 6 Martens T, et al. JAMA. 2021;325(22):2262-2272. 7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 8 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 9 Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202.

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes.

Dexcom G7 15 Day is now cleared in the US for people age 18 years and above with diabetes.

BEIJING--(BUSINESS WIRE)--Jun 8, 2026--

From June 1–6, 2026, the 2026 Beijing Inbound Tourism Development Conference was held in Beijing, co-organized by the Beijing Municipal Bureau of Culture and Tourism and the Bureau of International Exchange and Cooperation of China’s Ministry of Culture and Tourism. Focusing on immersive experiences and real-world tourism resources, the event aims to enhance Beijing’s inbound tourism offerings, stimulate cultural and tourism consumption, and strengthen the city’s global appeal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608991227/en/

Supported by major airlines including Air China and Cathay Pacific, the conference welcomed more than 300 travel trade professionals from over 40 countries and regions, including the UK, US, Canada, Germany, Singapore, Malaysia, and Russia. Officials highlighted China’s strong inbound tourism performance in 2025, with 154.5 million inbound visits, 35.17 million international arrivals, and over 30 million visa-free entries.

Beijing continues to improve travel convenience through the 240-hour visa-free transit policy, streamlined airport procedures, and broader acceptance of international payment methods. The city is also expanding sectors such as MICE, sports tourism, and urban leisure tourism while strengthening overseas promotion through its “Go Beijing” platform.

Centered on the theme of immersive Chinese daily-life experiences, the conference launched the “Discover the New Beijing” Top 10 Inbound Tourism Experiences, showcasing Beijing’s blend of traditional culture, local lifestyle, innovative retail, and technological advancement. In partnership with Booking.com, Tripadvisor, and more than 100 tourism experts, Beijing also introduced its first inbound tourism “Must-Eat” and “Must-Buy” lists, encouraging deeper cultural engagement beyond traditional sightseeing.

During the event, Beijing announced RMB 9 million in funding to support inbound tourism development and recognized outstanding local tourism enterprises. The city also welcomed 14 new overseas partners, bringing its global network of strategic tourism and OTA partners to 110.

Eight immersive inspection routes were introduced, connecting destinations such as Gubei Water Town, Huairou boutique homestays, Baidu’s autonomous driving showcase, and Shougang’s digital culture park. International delegates praised experiences including smart exoskeleton-assisted Great Wall tours and the integration of rural landscapes with Beijing’s historic heritage.

The conference also facilitated over 3,000 pre-arranged business meetings through its digital matchmaking platform. Concluding with a Beijing-style immersive performance at Tianqiao Performing Arts Center, the event reaffirmed Beijing’s commitment to showcasing a vibrant, innovative, and globally connected modern Chinese capital.

2026 Beijing Inbound Tourism Development Conference Kicks off, Unveiling 10 New Inbound Tourism Experiences to Boost Cultural and Tourism Consumption